Pain After Cesarean Section - A Danish Multicenter Cohort Study.
NCT06012747 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 752
Last updated 2024-06-11
Summary
Pain after a cesarean section is of moderate to severe intensity. A Danish multicenter study from 2021 used an obstetric Quality of Recovery score 24 hours after the cesarean section and found that 45% of 861 patients had experienced very severe pain during recovery.
This result was surprisingly high but also unspecific. Therefore, the investigators aim to investigate the intensity of pain experienced by patients at specific time intervals after the cesarean section e.g., every 6th hour. Additionally, the investigators will examine whether the pain has an impact on important functions for both the patients and the newborns, as well as assess the overall morphine consumption.
All Danish regions have approved the REDCap database as a secure way to collect and store data. REDCap can also send encrypted links that can be converted into SMS messages sent to the participants' mobile phones at fixed intervals, allowing participants to enter data directly into the secure system. The investigators also aim to feasibility test the system.
When a child is delivered by cesarean section, it is an expectation that the mother can take care of herself and the baby a few hours after the surgery. However, severe pain can hinder this. Therefore, it is important to investigate whether pain relief for our patients is sufficient.
Based on response rates and the frequency of outcomes, data from this observational study can support the design of a future national multicenter randomized controlled trial (RCT) with a focus on postoperative pain intervention. The incidences of binary outcome measures and standard deviations of continuous outcome measures will support the sample size calculations for our RCT.
Conditions
- Pain
- Cesarean Section
- Recovery
Interventions
- OTHER
-
Questionnaire
The patients receive a questionnaire every 6 hours during the first 24 hours after their cesarean section, and again after 2, 7, and 30 days.
Sponsors & Collaborators
-
Nordsjaellands Hospital
lead OTHER
Principal Investigators
-
Patricia Duch, MD · Hillerod Hospital, Denmark
-
Helene Nedergaard, MD, Ph.D · Kolding Sygehus
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2024-05-31
- Completion
- 2024-05-31
Countries
- Denmark
Study Locations
More Related Trials
-
Presence of the Father During Hyperacute Cesarean Section in General Anesthesia
NCT04948892 ·Status: COMPLETED
-
Insufficient Regional Anesthesia and Conversion to General Anesthesia for Cesarean Section A Qualitative Multicenter Study
NCT06669156 ·Status: RECRUITING
-
Pain After Cesarean Sectio.
NCT03730246 ·Status: UNKNOWN
-
Insufficient Regional Anesthesia for Cesarean Section: Mothers' Experiences A Qualitative Study
NCT07134179 ·Status: NOT_YET_RECRUITING
-
Prediction of Postoperative Pain by an Electrical Pain Stimulus
NCT00374504 ·Status: COMPLETED
-
Persistent Pain After CS Delivery
NCT01996592 ·Status: COMPLETED
-
Postoperative Pain After Caesarian Section
NCT05659823 ·Status: COMPLETED ·Phase: PHASE4
-
Routine Cervical Dilatation at the Non-labour Caesarean Section and Its Influence on Postoperative Pain
NCT03513237 ·Status: COMPLETED ·Phase: NA
-
Multiparas Attitude to Outpatient Cesarean Section
NCT05024370 ·Status: COMPLETED
-
Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Section
NCT02279628 ·Status: UNKNOWN ·Phase: PHASE4
-
Dexmedetomidine Wound Infiltration in Cesarean Section
NCT03382938 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Intrathecal Morphine for Postoperative Pain Management Following Planned Caesarean Section
NCT06797973 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Effect of Postoperative Analgesia Techniques With ObsQoR-10
NCT06978491 ·Status: COMPLETED ·Phase: NA
-
Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia
NCT07023497 ·Status: RECRUITING ·Phase: NA
-
Low Pain Prediction in Cesarean Section Patients
NCT02143141 ·Status: TERMINATED ·Phase: PHASE4
-
Timing of Planned Caesarean Section and Morbidity of the Newborn
NCT00835003 ·Status: COMPLETED ·Phase: NA
-
Impact of a Strategy Combining Morphine Savings and Anesthesia Technique on the Quality of Post-operative Rehabilitation
NCT04377984 ·Status: TERMINATED
-
Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
NCT04693572 ·Status: UNKNOWN
-
How Well do the Current Cesarean Deliveries Adhere to the Published ERAS Guidelines?
NCT05396417 ·Status: UNKNOWN
-
Postoperative Pain Management of Caesarean Section
NCT05009771 ·Status: RECRUITING
-
Sharp Versus Blunt Fascial Incision at Caesarean Section
NCT01297725 ·Status: COMPLETED ·Phase: NA
-
Oral Self Medication Versus IV Administration of Pain Killers After Caesarian Delivery
NCT01566253 ·Status: COMPLETED ·Phase: PHASE4
-
Perinatal Morbidity Factors During Cesarean Section
NCT03928795 ·Status: COMPLETED
-
Pain Score and Opioid Consumption of Index and Previous Cesarean Delivery
NCT06178458 ·Status: NOT_YET_RECRUITING
-
Comparison of 0.1 and 0.05mg Intrathecal Morphine for Post-cesarean Analgesia.
NCT03427463 ·Status: COMPLETED ·Phase: EARLY_PHASE1